Sam Waksal, the former chief executive of ImClone Systems Inc., whose insider trading scam sent him and Martha Stewart to prison, Monday announced an acquisition meant to catapult him back into the biotech game.
Waksal said that his drug company Kadmon Pharmaceuticals has bought the privately held Three Rivers Pharmaceuticals and that its treatments for hepatitis C, infections and cancer will be the backbone of his new enterprise. Get the full story »
